DOI: https://doi.org/10.22141/2224-0551.14.8.2019.190841

Functional dyspepsia in children. Problems and prospects of symptomatic therapy

O.Yu. Belousova, L.V. Kazaryan

Abstract


The article deals with the problem of functional dyspepsia. Functional dyspepsia is characterized by diverse non-specific symptoms such as discomfort, troublesome early satiety, nausea, or epigastric pain or burning. It can easily be overlooked as the symptoms overlap with gastro-oesophageal reflux disease and irritable bowel syndrome that requires diagnosis specification. The pathophysiology of functional dyspepsia is not completely understood. It is thought to be associated with upper gastrointestinal inflammation and motility disturbances, which may be triggered by an infectious or allergenic agent, or a change in the intestinal microbiome. While functional dyspepsia is distressing and affects the quality of life, it has no long-term impact on mortality. There are many treatment options available, with varying levels of evidence of effectiveness. These include dietary modification, acid suppression, prokinetic drugs including tricyclic antidepressants and psychological therapy. Proton pump inhibitors (PPIs) and prokinetics are commonly used first-line medications. The paper paid attention to a preparation Domrid containing domperidone (prokinetic).

Keywords


functional dyspepsia; Rome criteria; treatment; domperidone; Domrid

References


Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006 May 7;12(17):2661-6. doi: 10.3748/wjg.v12.i17.2661.

Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016 May;150(6):1380-92. doi: 10.1053/j.gastro.2016.02.011.

Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2006 Apr;130(5):1519-26. doi: 10.1053/j.gastro.2005.11.065.

Ganesh M, Nurko S. Functional dyspepsia in children. Pediatr Ann. 2014 Apr;43(4):e101-5. doi: 10.3928/00904481-20140325-12.

Tkach SМ. Functional Dyspepsia in the Light of the Rome IV Criteria. Gastroenterology. 2016;4(62):65-71. doi: 10.22141/2308-2097.4.62.2016.81097. (in Russian).

Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252.

Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016 May;150(6):1257-61. doi: 10.1053/j.gastro.2016.03.035.

Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017 Apr 30;23(2):151-163. doi: 10.5056/jnm16214.

Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015 Nov 5;373(19):1853-63. doi: 10.1056/NEJMra1501505.

Mearin F, Ciriza C, Mínguez M, et al. Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig. 2016 Jun;108(6):332-63. doi: 10.17235/reed.2016.4389/2016.

Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr;130(5):1466-79. doi: 10.1053/j.gastro.2005.11.059.

Ortiz AM, Cooper CJ, Gomez Y, Sarosie I, McCallum RW. Clinical Experience and Cardiovascular Safety Profile of Domperidone Therapy for Nausea and Vomiting. Gastroenterology. 2014;146(5 Suppl 1):S268. doi: 10.1016/S0016-5085(14)60948-3.

van Roeden SE, Belle-van Meerkerk G, van Tuyl SA, van de Ree MA, Muller AF. Domperidone and the risk of sudden cardiac death. Ned Tijdschr Geneeskd. 2013;157(45):A6770. (in Dutch).






Copyright (c) 2020 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта